ArticleInternational journal of breast cancer2012

Current Status of Poly(ADP-ribose) Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer.

David J Hiller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.